Company intelligence / Profile preview

profil.lab

Neuss/Düsseldorf area*, North Rhine-Westphalia, Germanyfacebook.com ↗

Ownership: Private
Development stage: Other

Overview

Profil specializes in early-phase clinical trials for diabetes and obesity therapies, including pharmacodynamic characterization of new drugs/devices. They have contributed to the development of all major currently available anti-diabetic compounds through sophisticated experimental methods such as glucose clamp studies combined with isotope dilution techniques and tissue biopsies.

Therapeutic areas: Endocrinology
Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Partnerships

Numerous partnerships with pharmaceutical companies developing diabetes/obesity drugs/devices; specifics not publicly listed.

Beyond the preview

Go deeper on profil.lab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on profil.lab.

Explore the full profile